× Your free unusual options activity stream is delayed by a few hours. Select a subscription plan to access historical and intraday data.
Next earnings announcement in about 2 hours

Intercept Pharmaceuticals is a biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics in treating chronic liver diseases. Its product pipeline is OCALIVA which is used for the treatment of primary biliary cholangitis, nonalcoholic steatohepatitis, primary sclerosing cholangitis, and biliary atresia. The company was founded by Mark E. Pruzanski and Roberto Pellicciari on September 4, 2002 and is headquartered in New York, NY.

UOA Trade History
DecJanFeb
Loading...


Bullish Option Contracts

Intercept Pharmaceuticals, Inc. call option contracts that are bought on or above the market's asking price OR put option contracts that are sold on or less than the market's bid price - expecting a move to the updside



Loading...
Loading...

Bearish Option Contracts

Intercept Pharmaceuticals, Inc. put option contracts that are bought on or above the market's asking price OR call option contracts that are sold on or less than the market's bid price - expecting a move to the downside



Loading...
Loading...
How To Trade ICPT Unusual Options Activity There are many ways to interpret UOA. Some common strategies include looking at the strike prices and comparing them to the current stock price for Intercept Pharmaceuticals, Inc.. A bullish signal can be intrerpreted if you notice a large amount of contracts traded for strikes that are considered out of the money and expiring in the near future. You can then compare the overall volume for that strike to the open interest at the beginning of the day. A larger volume of option contracts traded compared to the open interest would mean this is a new position that is being opened.